November 28, 2025

SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform

SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform

Cambridge, UK, 20 November 2025: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, today announced a collaboration with Pacific Biosciences (PacBio), a pioneer in long-read sequencing, to automate PacBio’s Kinnex™ full-length RNA-seq library preparation on SPT Labtech’s firefly® liquid handling platform. The automated workflow will improve reproducibility and scalability in large-scale transcriptomics studies by reducing manual steps in library preparation.


103-072-000 Kinnex for bulk Iso-Seq kitManual preparation of RNA-seq libraries can be time-consuming, and risks introducing variability that can affect data quality. By integrating the Kinnex full-length RNA kit with the firefly platform, researchers are now able to process samples more efficiently while maintaining the accuracy and integrity required for large-scale and clinical studies.

The automated walk-away workflow and processing enables:

•    Reduced hands-on time – manual pipetting decreased by up to 80%, allowing researchers to focus on data analysis and experimental design.
•    Improved consistency – user-to-user and day-to-day variation is minimized.
•    Scalability – generation of high-quality, full-length transcript data is enabled at higher throughput, to support large-scale genomics initiatives.

firefly Banner (2)At Seattle Children’s Genomics and Spatial Biology CoLab, researchers are already using the automated firefly-Kinnex workflow to support high-throughput isoform discovery. The workflow supports the same Kinnex chemistry used in the 1000 Genomes Long Read Sequencing Project1, which is advancing large-scale studies of transcriptome diversity across human populations.

Press Release Template (1)

Morten Frost, Chief Commercial Officer at SPT Labtech, commented: “Our collaboration with PacBio is all about empowering the researcher. The firefly platform is built for reliable, flexible automation. By seamlessly integrating industry-leading chemistry, we are offering a validated solution that doesn’t just automate a step – it guarantees the quality and scalability required to push the boundaries of transcriptomic science.”

Press Release Template-1

David Miller, VP of Marketing at PacBio, added: “Long-read RNA sequencing provides the most complete view of the transcriptome, and more customers are looking to apply Kinnex on population-scale projects. The firefly automation brings consistency to library processing, making it dramatically easier and more efficient for labs to adopt full-length RNA workflows, ultimately speeding up the pace of discovery.”

1.    The 1000 Genomes Long Read Sequencing Project – Automated on firefly®

Our latest News

discover more
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

New AI System Provides Treatment Recommendations for Complex Blood Cancers

New AI System Provides Treatment Recommendations for Complex Blood Cancers

Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute, and the Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has shown a high degree of agreement with the recommendations of experienced experts and could significantly improve […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp